Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP658743.RACrIbWDVlvE_2m5tVdbnlRuevXAVU_e6zLnA1o8y0_EY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP658743.RACrIbWDVlvE_2m5tVdbnlRuevXAVU_e6zLnA1o8y0_EY130_assertion type Assertion NP658743.RACrIbWDVlvE_2m5tVdbnlRuevXAVU_e6zLnA1o8y0_EY130_head.
- NP658743.RACrIbWDVlvE_2m5tVdbnlRuevXAVU_e6zLnA1o8y0_EY130_assertion description "[In this study, we have used a combination of transcriptomics and proteomics technologies to investigate the response of human hepatoma PLC/PRF/5 cells to prohibitin silencing to define in detail the biological function of hepatic Phb1 and to elucidate potential prohibitin-dependent mechanisms participating in the maintenance of the transformed phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP658743.RACrIbWDVlvE_2m5tVdbnlRuevXAVU_e6zLnA1o8y0_EY130_provenance.
- NP658743.RACrIbWDVlvE_2m5tVdbnlRuevXAVU_e6zLnA1o8y0_EY130_assertion evidence source_evidence_literature NP658743.RACrIbWDVlvE_2m5tVdbnlRuevXAVU_e6zLnA1o8y0_EY130_provenance.
- NP658743.RACrIbWDVlvE_2m5tVdbnlRuevXAVU_e6zLnA1o8y0_EY130_assertion SIO_000772 20186755 NP658743.RACrIbWDVlvE_2m5tVdbnlRuevXAVU_e6zLnA1o8y0_EY130_provenance.
- NP658743.RACrIbWDVlvE_2m5tVdbnlRuevXAVU_e6zLnA1o8y0_EY130_assertion wasDerivedFrom befree-20140225 NP658743.RACrIbWDVlvE_2m5tVdbnlRuevXAVU_e6zLnA1o8y0_EY130_provenance.
- NP658743.RACrIbWDVlvE_2m5tVdbnlRuevXAVU_e6zLnA1o8y0_EY130_assertion wasGeneratedBy ECO_0000203 NP658743.RACrIbWDVlvE_2m5tVdbnlRuevXAVU_e6zLnA1o8y0_EY130_provenance.